Literature DB >> 18046634

Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics.

Timothy J Henrich1, Naudia Lauder, Mayur M Desai, Andre N Sofair.   

Abstract

The purpose of this study is to examine the association of alcohol abuse and injection drug use (IDU) with the immunologic and virologic responses to highly active antiretroviral treatment (HAART) in urban community health clinics. The medical records of 293 HIV-infected adult patients who visited either of two urban health clinics in New Haven, Connecticut, from June 2003 to December 2004 were retrospectively reviewed. Changes in mean CD4 lymphocyte counts and undetectable viral loads were compared before and after the initiation of HAART for patients categorized into one of four substance abuse groups: history of neither alcohol abuse nor IDU, alcohol abuse only, IDU only, or both. Unadjusted mean improvements in CD4 count for the four groups were 136, 97, 20, and 27, respectively. In a linear regression model adjusted for age, gender, and baseline CD4 count, history of IDU only (P = 0.037) and a combination of alcohol abuse and IDU (P = 0.038) were associated with a lesser increase in CD4 count after HAART compared with those with neither alcohol nor IDU. No significant associations were found between substance abuse history and changes in detectable viral load. Our results show that many patients at urban health clinics have a history of either injection drug use or alcohol abuse, and that injection drug use is negatively associated with the immunologic response to HAART in urban HIV-infected individuals. This study highlights the importance for clinicians of understanding the negative associations of substance abuse with the treatment response of HIV-infected patients at urban health centers.

Entities:  

Mesh:

Year:  2008        PMID: 18046634     DOI: 10.1007/s10900-007-9069-1

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  38 in total

1.  Initiation, changes in use and effectiveness of highly active anti-retroviral therapy in a cohort of injecting drug users.

Authors:  J M Egea; R Muga; G Sirera; B Clotet; J Tor; M Ardèvol; C Rey-Joly; A Muñoz
Journal:  Epidemiol Infect       Date:  2002-10       Impact factor: 2.451

2.  Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.

Authors:  Tanya Telfair Sharpe; Lisa M Lee; Allyn K Nakashima; Laurie D Elam-Evans; Patricia L Fleming
Journal:  J Community Health       Date:  2004-04

3.  A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival.

Authors:  A Mocroft; S Madge; A M Johnson; A Lazzarin; N Clumeck; F D Goebel; J P Viard; J Gatell; A Blaxhult; J D Lundgren
Journal:  J Acquir Immune Defic Syndr       Date:  1999-12-01       Impact factor: 3.731

4.  The effect of a multidisciplinary program on HAART adherence.

Authors:  Pamela Frick; Kenneth Tapia; Philip Grant; Martina Novotny; Jane Kerzee
Journal:  AIDS Patient Care STDS       Date:  2006-07       Impact factor: 5.078

5.  Older age and plasma viral load in HIV-1 infection.

Authors:  Karl Goodkin; Paul Shapshak; Deshratn Asthana; Wenli Zheng; Mauricio Concha; Frances L Wilkie; Rebeca Molina; Diana Lee; Paola Suarez; Stephen Symes; Imad Khamis
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

6.  Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study.

Authors:  Ulrik Bak Dragsted; Amanda Mocroft; Stefano Vella; Jean-Paul Viard; Ann-Britt E Hansen; George Panos; Danielle Mercey; Ladislav Machala; Andrzej Horban; Jens D Lundgren
Journal:  J Infect Dis       Date:  2004-06-09       Impact factor: 5.226

7.  Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.

Authors:  Evan Wood; Julio S G Montaner; Benita Yip; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg
Journal:  Antivir Ther       Date:  2004-04

8.  Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women.

Authors:  Judith A Cook; Dennis Grey; Jane Burke; Mardge H Cohen; Alejandra C Gurtman; Jean L Richardson; Tracey E Wilson; Mary A Young; Nancy A Hessol
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

9.  Adherence to HAART among HIV-infected persons in rural Louisiana.

Authors:  Hamish Mohammed; Lyn Kieltyka; Gwangi Richardson-Alston; Manya Magnus; Hala Fawal; Sten H Vermund; Janet Rice; Patricia Kissinger
Journal:  AIDS Patient Care STDS       Date:  2004-05       Impact factor: 5.078

10.  Nonadherence among HIV-infected injecting drug users: the impact of social instability.

Authors:  Anne-Déborah Bouhnik; Margaret Chesney; Patrizia Carrieri; Hervé Gallais; Jacques Moreau; Jean-Paul Moatti; Yolande Obadia; Bruno Spire
Journal:  J Acquir Immune Defic Syndr       Date:  2002-12-15       Impact factor: 3.731

View more
  9 in total

1.  Coping styles and illicit drug use in older adults with HIV/AIDS.

Authors:  Linda M Skalski; Kathleen J Sikkema; Timothy G Heckman; Christina S Meade
Journal:  Psychol Addict Behav       Date:  2013-02-25

Review 2.  A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.

Authors:  Marwan M Azar; Sandra A Springer; Jaimie P Meyer; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2010-08-11       Impact factor: 4.492

3.  Do coping styles mediate the relationship between substance use and educational attainment and antiretroviral adherence?

Authors:  David A Martinez; Kathy Goggin; Delwyn Catley; Mary M Gerkovich; Karen Williams; Julie Wright; Jannette Berkley-Patton
Journal:  AIDS Behav       Date:  2012-11

4.  Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users.

Authors:  Ryan P Westergaard; Timothy Hess; Jacquie Astemborski; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

Review 5.  Biomedical consequences of alcohol use disorders in the HIV-infected host.

Authors:  Patricia E Molina; Gregory J Bagby; Steve Nelson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

6.  The effect of history of injection drug use and alcoholism on HIV disease progression.

Authors:  Viviane Dias Lima; Thomas Kerr; Evan Wood; Tsubasa Kozai; Kate A Salters; Robert S Hogg; Julio S G Montaner
Journal:  AIDS Care       Date:  2013-06-14

7.  U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.

Authors:  Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

8.  Alcohol Consumption, Progression of Disease and Other Comorbidities, and Responses to Antiretroviral Medication in People Living with HIV.

Authors:  Manuela G Neuman; Michelle Schneider; Radu M Nanau; Charles Parry
Journal:  AIDS Res Treat       Date:  2012-03-11

9.  Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomes.

Authors:  Cláudio Moss da Silva; Raúl Andrés Mendoza-Sassi; Luisa Dias da Mota; Maíba Mikhael Nader; Ana Maria Barral de Martinez
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.